SreevidyaKannoorpattiSubbarayanMD
Endocrinology • Atlanta, GADiabetes, Lipid Metabolism
Assistant professor, division of Endocrinology at Emory St. Joseph’s hospital
Dr. Subbarayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Emory Saint Joseph's Hospital
5665 Peachtree Dunwoody Rd
Atlanta, GA 30342Phone+1 404-778-3280
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011
University of North DakotaResidency, Internal Medicine, 2005 - 2008
JSS Medical College MysoreClass of 2001
Certifications & Licensure
GA State Medical License 2021 - 2026
FL State Medical License 2012 - 2022
OH State Medical License 2009 - 2012
ND State Medical License 2005 - 2009- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 2 citationsClinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational study.Naykky Singh Ospina, Chandani Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, Jessica Hidalgo
Endocrine. 2024-02-01 - 3 citationsPatient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study.Chandani Patel Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, Jessica Hidalgo, Sandra Hartasanchez
Endocrine. 2023-04-01 - 8 citationsDevelopment and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.Naykky Singh Ospina, Diliara Bagautdinova, Ian Hargraves, Diana Barb, Sreevidya Subbarayan
Clinical Endocrinology. 2021-09-29
Lectures
- High Risk of Nonalcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH) in Obese Patients with Type 2 Diabetes Mellitus (T2DM) and Normal Liver AminotransferasesGainesville, FL - 6/16/2014
- Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Disease Severity among African Americans (AA) with Prediabetes (preDM) or Type 2 Diabetes (T2DM)Gainesville, FL - 6/16/2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
